Anti-tumor necrosis factor agents and placental transfer: relevant clinical data for rational decision-making
- PMID: 23247325
- DOI: 10.1016/j.cgh.2012.11.030
Anti-tumor necrosis factor agents and placental transfer: relevant clinical data for rational decision-making
Comment on
-
Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure.Clin Gastroenterol Hepatol. 2013 Mar;11(3):318-21. doi: 10.1016/j.cgh.2012.10.024. Epub 2012 Oct 25. Clin Gastroenterol Hepatol. 2013. PMID: 23103819
-
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.Clin Gastroenterol Hepatol. 2013 Mar;11(3):286-92; quiz e24. doi: 10.1016/j.cgh.2012.11.011. Epub 2012 Nov 28. Clin Gastroenterol Hepatol. 2013. PMID: 23200982 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
